CAS 30636-90-9: (20S)-Protopanaxadiol

(20S)-Protopanaxadiol analytical standard provided with chromatographic purity, to be used as reference material for qualitative determination.

Cyclic alcohol

20(S)-Protopanaxdiol is a ginsenoside derivative, which is a type of triterpenoid saponin. It is derived from the roots of Panax ginseng, a plant traditionally used in East Asian medicine. The mode of action of this compound involves modulation of various cellular pathways, including the inhibition of cell proliferation and induction of apoptosis in cancer cells. It has been shown to interact with multiple molecular targets, influencing signaling pathways such as PI3K/Akt and MAPK, which are critical for cell growth and survival. The compound’s potential uses and applications are primarily in the field of oncology, where it is explored for its ability to enhance the efficacy of chemotherapeutic agents and overcome drug resistance. Additionally, due to its anti-inflammatory and antioxidant properties, it is being investigated for its potential benefits in managing metabolic disorders and neurodegenerative diseases. Overall, 20(S)-Protopanaxdiol represents a promising candidate for further research to develop novel therapeutic strategies.

(20S)-Protopanaxadiol

(20S)-Protopanaxadiol

(20S)-Protopanaxadiol (20-Epiprotopanaxadiol) (20-Epiprotopanaxadiol), an apoptosis inducer, is an aglycon metabolic derivative of the protopanaxadiol-type

Applications (20S)-Protopanaxadiol is used in the treatment of cerebral ischemic injury and the reversal of oxidative stress. A novel class of AMP-activated protein kinase (AMPK) inhibitors affecting glucose and lipid metabolism. References Xu, H. et al.: Exp. Ther. Med., 7, 165 (2014); Liu, J. et al.: Eur. j. Med. Chem., 79, 340 (2014);